Will initiate a Phase 2b/3 study in 2Q 2021 Appoints Kenneth Sall, M.D. as Medical Head, Ophthalmology, to lead efforts...
LONDON, UK / ACCESSWIRE / December 1, 2020 / World High Life PLC (AQSE:LIFE)(OTCQB:WRHLF) announces the appointment of Mr. Robert Payment...
SAN ANTONIO, TX, Dec. 1, 2020 /PRNewswire/ -- The 43rd Virtual San Antonio Breast Cancer Symposium (SABCS®) is just one week...
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the...
BILLERICA, Mass.--(BUSINESS WIRE)--OmniGuide Holding, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announces...
WESTLAKE, Ohio--(BUSINESS WIRE)--Nordson Corporation (NASDAQ-NDSN) announced the recent appointments of Dr. John DeFord, executive vice president and chief technology officer...
SAN DIEGO, Nov. 30, 2020 /PRNewswire/ -- Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has...
Includes Full Exercise of Underwriters' Overallotment Option EDISON, NJ / ACCESSWIRE / November 30, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA),...
Recruitment of 232 patients completed ahead of schedule with minimal impact by the Covid-19 pandemic Top-line results expected to be...
MURFREESBORO, TN / ACCESSWIRE / November 30, 2020 / National Health Investors, Inc. (NYSE:NHI) today announced that it will fund...
A significant percentage of COVID-19 recovery patients suffer from long-term diarrhea or other gastrointestinal disfunctions Non-binding terms to fund activities...
BAY HARBOR ISLANDS, FL / ACCESSWIRE / November 30, 2020 / (OTC PINK:KNSCD) Med Smart Group, Inc's., Subsidiary company, Med...
CORNWALL, ON / ACCESSWIRE / November 30, 2020 / Andrew Hanna, a dedicated compound pharmacist and active member of his...
WESTPORT, CT / ACCESSWIRE / November 30, 2020 / Solos Endoscopy, Inc. (OTC PINK:SNDY) is pleased to announce that as...
COVID-19 prophylactic vaccine candidate: CVnCoV on track for advanced clinical testing Interim Phase 1 data showed generally good tolerability for...
VANCOUVER, BC / ACCESSWIRE / November 30, 2020 / (CSE:OVAT) (OTC:OVATF) Ovation Science Inc. ("Ovation" or the "Company") is pleased...
- FDA Grants Priority Review and Sets PDUFA Date of May 30, 2021 -- Application Being Evaluated Under FDA's Real-Time...
Compared to recombinant human IL-12, SON-1010 demonstrated an enhanced pharmacokinetic (PK) profile that was similar to IgG antibodies SON-1010 continues...
IntelliSpace Portal 12 Photorealistic Chest 3D Image IntelliSpace Portal 12 Photorealistic Vascular 3D Image IntelliSpace Portal 12 with AI Capabilities...
Company advancing Brilacidin as a next-generation broad-spectrum antiviral for the treatment of common colds and deadly coronavirus infectionsWAKEFIELD, Mass., Nov....